tirzepatide degradation GLP-1 Drug Impurities & Does tirzepatide go bad? Signs,
Description
The figures above are averages from clinical trials of GLP-1 medications
Plateaus happen
Additionally, tirzepatide is only currently FDA approved for diabetes and the expectation is it will be approved within the coming year for weight loss
Again, this is secondary to the glucose-dependent mechanism of incretin-based therapies wherein increased insulinotropic activity occurs only in the presence of hyperglycemia
This means it acts on both the GLP-1 and GIP pathways, which are involved in appetite regulation, insulin secretion, and fat metabolism
